Xeomin
Xeomin is an originator product from Merz Pharma (Schweiz) AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 123.70 to CHF 443.55 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Merz Pharma (Schweiz) AG
- ATC code
- M03AX01
- IT group
- 01.13 Myorelaxantia
- Active substances
- Toxinum botulinicum A
- Preparation type
- Originator product
- On the SL since
- 01/08/2013
- Last price change
- 01/09/2026
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Trockensub 200 E | Durchstf 1 Stk | CHF 392.76 | CHF 443.55 | 01/09/2026 | A | 7680620800032 |
| Trockensub 50 E | Durchstf 1 Stk | CHF 98.66 | CHF 123.70 | 01/08/2013 | A | 7680620800018 |
| Trockensub 100 E | Durchstf 1 Stk | CHF 196.38 | CHF 230.00 | 01/08/2013 | A | 7680620800025 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Maximal 4 Behandlungen pro Jahr bei fokaler Spastik der oberen und/oder unteren Extremitäten.
Blepharospasmus bei Erwachsenen, Torticollis spasmodicus bei Erwachsenen.
Chronische beeinträchtigende Sialorrhoe bei Erwachsenen:
- Maximal 4 Behandlungen pro Jahr bei chronischer Sialorrhoe, welche seit mindestens 6 Monaten besteht.
- Der DSFS Summenwert beträgt ≥ 6.
- Der Sialorrhoe liegt eine neurologische Indikation zugrunde und eine medikamentöse Ursache konnte ausgeschlossen werden.
- Einsatz als medikamentöse Monotherapie.
- Die Injektion darf nur nach einer Abklärung durch einen Neurologen und unter Ultraschallführung durch Neurologen oder HNO-Ärzte erfolgen.
More preparations in this group
FAQ
Is Xeomin covered by Swiss health insurance?
Yes, but only under conditions. Xeomin is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Xeomin cost in Switzerland?
The public price is the maximum price set by the FOPH and for Xeomin ranges from CHF 123.70 to CHF 443.55 per pack. The ex-factory price ranges from CHF 98.66 to CHF 392.76. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages